Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Immune Deficiency”

1,058 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,058 results

Testing effectiveness (Phase 2)Study completedNCT02071095
What this trial is testing

Enhancement by Poly-ICLC During HIV-1 Infection

Who this might be right for
HIV-1 Infected Adults With Chronic HIV-1 Infection
Nina Bhardwaj 15
Not applicableStudy completedNCT01134939
What this trial is testing

Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data

Who this might be right for
HIV Infections
Boehringer Ingelheim 265
Not applicableStudy completedNCT00002081
What this trial is testing

Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease

Who this might be right for
HIV Infections
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT02987530
What this trial is testing

National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 101
Not applicableStudy completedNCT01524900
What this trial is testing

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Who this might be right for
HIV Infections
Boehringer Ingelheim 398
Post-approval studies (Phase 4)Study completedNCT00192621
What this trial is testing

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Who this might be right for
HIV InfectionsDyslipidemiasGlucose Metabolism Disorders+3 more
Kirby Institute 50
Early research (Phase 1)Study completedNCT00001644
What this trial is testing

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT04930744
What this trial is testing

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Who this might be right for
TuberculosisPulmonary TuberculosisHIV Coinfection
University of Massachusetts, Worcester 112
Early research (Phase 1)Study completedNCT02413645
What this trial is testing

Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients

Who this might be right for
HIV-infection
Judit Pich Martínez 21
Large-scale testing (Phase 3)Study completedNCT00523211
What this trial is testing

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC 506
Not applicableStudy completedNCT02191293
What this trial is testing

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

Who this might be right for
HIV Infections
Boehringer Ingelheim 228
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT01717287
What this trial is testing

The Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 32
Testing effectiveness (Phase 2)WithdrawnNCT00000752
What this trial is testing

Preventing Frequent Sinus Infections in HIV-Infected Patients

Who this might be right for
HIV InfectionsSinusitis
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableLooking for participantsNCT00055172
What this trial is testing

Genetic Basis of Immunodeficiency

Who this might be right for
Severe Combined Immunodeficiency
National Heart, Lung, and Blood Institute (NHLBI) 100
Post-approval studies (Phase 4)Study completedNCT00127972
What this trial is testing

2NN & CHARM Long-Term Follow-up Study

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 763
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Post-approval studies (Phase 4)Study completedNCT04388904
What this trial is testing

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Who this might be right for
HIV-1-infection
The Crofoot Research Center, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT00031044
What this trial is testing

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT00001075
What this trial is testing

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Load More Results